Synapsin-caveolin-1 gene therapy preserves neuronal and synaptic morphology and prevents neurodegeneration in a mouse model of AD is a research paper published in Molecular Therapy — Methods & Clinical Development (2021). On theSindex it has a DataRank of 0. It has been cited 22 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: S10OD023527
U.S. Department of Veterans Affairs
Grant: BX003671
U.S. Department of Veterans Affairs
Grant: GM085179
U.S. Department of Veterans Affairs
Grant: NS073653
U.S. Department of Veterans Affairs
Grant: R01NS109075
U.S. Department of Veterans Affairs
Grant: R56AG057469
BLRD VA
Grant: I01 BX003671
NIA NIH HHS
Grant: P30 AG010124
NINDS NIH HHS
Grant: R01 NS073653
NIGMS NIH HHS
Grant: R01 GM085179
National Institutes of Health
Grant: 1S10OD023527-01
JEOL JEM-1400Plus Transmission Electron Microscope
National Institutes of Health
Grant: 5R01GM085179-07
The Role of RhoGTPases in Anesthetic-Mediated Neurotoxicity
National Institutes of Health
Grant: 5R01NS073653-03
Neuronal-targeted caveolin-1 as a therapy for traumatic brain injury
National Institutes of Health
Grant: 5R01NS109075-04
Development of Molecular Probe Inhibitors of Pathogenic, Cytosolic Cathespin B in Traumatic Brain Injury and Alzheimers Disease Neurodegeneration
National Institutes of Health
Grant: 1R56AG057469-01
Biogenesis of Exosomes, Secretion, and Trafficking in Alzheimer's Disease
Fields of Study
Keywords
Sustainable Development Goals